1.Immunogenicity and immune persistence of human rabies vaccine (Vero cell) in healthy people aged 10-17 years
Zhenzhen LIANG ; Yugang SHEN ; Xiaosong HU ; Bo XING ; Xinpei ZHANG ; Yingping CHEN ; Yu MAO ; Huakun LYU
Chinese Journal of Microbiology and Immunology 2025;45(2):135-140
Objective:To evaluate the immunogenicity and immune persistence of human rabies vaccine (Vero cell) in healthy people aged 10-17 years and compare it with a group of adults aged 18-60 years.Methods:This study was conducted between July 2021 and November 2022 with Shangyu district and Shengzhou city of Shaoxing city, Zhejiang Province selected as the research sites. Zagreb regimen (2-1-1 schedule) and Essen regimen (1-1-1-1-1 schedule) were used for rabies vaccine administration. Serum samples were collected at different time points before and after immunization to compare the differences in seropositivity rates and geometric mean concentrations (GMC) between the 10-17 age group and the 18-60 age group.Results:A total of 1 200 healthy participants aged 10-60 were included, with 157 individuals (13.1%) in the 10-17 age group and 1 043 individuals (86.9%) in the 18-60 age group. Both groups displayed a nearly 100% seropositivity rate at 3, 6 and 12 months, and the participants in the same age group had similar antibody levels. The GMC of antibodies gradually increased after vaccination and peaked on 14 d. The 10-17 age group showed higher GMC of antibodies than the 18-60 age group at 14 d after the first dose (Zagreb regimen: 81.85 IU/ml vs 63.15 IU/ml, t=2.411, P=0.018; Essen regimen: 86.61 IU/ml vs 69.24 IU/ml, t=3.906, P<0.001). Similar differences were observed in the GMC of antibodies at 14 d and 3 months after the full vaccination course, but these differences gradually decreased and disappeared at 6 and 12 months after vaccination. Conclusions:Human rabies vaccine (Vero cell) has lasting immune protection in all participants within one year after vaccination, with no significant differences between the two vaccination regimens. Participants aged 10-17 have higher antibody levels compared to adults aged 18-60, but there is no significant difference in immune persistence between the two age groups.
2.Immunogenicity and immune persistence of human rabies vaccine (Vero cell) in healthy people aged 10-17 years
Zhenzhen LIANG ; Yugang SHEN ; Xiaosong HU ; Bo XING ; Xinpei ZHANG ; Yingping CHEN ; Yu MAO ; Huakun LYU
Chinese Journal of Microbiology and Immunology 2025;45(2):135-140
Objective:To evaluate the immunogenicity and immune persistence of human rabies vaccine (Vero cell) in healthy people aged 10-17 years and compare it with a group of adults aged 18-60 years.Methods:This study was conducted between July 2021 and November 2022 with Shangyu district and Shengzhou city of Shaoxing city, Zhejiang Province selected as the research sites. Zagreb regimen (2-1-1 schedule) and Essen regimen (1-1-1-1-1 schedule) were used for rabies vaccine administration. Serum samples were collected at different time points before and after immunization to compare the differences in seropositivity rates and geometric mean concentrations (GMC) between the 10-17 age group and the 18-60 age group.Results:A total of 1 200 healthy participants aged 10-60 were included, with 157 individuals (13.1%) in the 10-17 age group and 1 043 individuals (86.9%) in the 18-60 age group. Both groups displayed a nearly 100% seropositivity rate at 3, 6 and 12 months, and the participants in the same age group had similar antibody levels. The GMC of antibodies gradually increased after vaccination and peaked on 14 d. The 10-17 age group showed higher GMC of antibodies than the 18-60 age group at 14 d after the first dose (Zagreb regimen: 81.85 IU/ml vs 63.15 IU/ml, t=2.411, P=0.018; Essen regimen: 86.61 IU/ml vs 69.24 IU/ml, t=3.906, P<0.001). Similar differences were observed in the GMC of antibodies at 14 d and 3 months after the full vaccination course, but these differences gradually decreased and disappeared at 6 and 12 months after vaccination. Conclusions:Human rabies vaccine (Vero cell) has lasting immune protection in all participants within one year after vaccination, with no significant differences between the two vaccination regimens. Participants aged 10-17 have higher antibody levels compared to adults aged 18-60, but there is no significant difference in immune persistence between the two age groups.
3.Major changes in the Dietary Ration for Military Personnel standard(GJB 826C-2022)and their basis
Yugang JIANG ; Hui SHEN ; Peng DU ; Changjiang GUO ; Shuguang DU ; Zhanwei JIANG
Military Medical Sciences 2024;48(8):561-564
The Dietary Ration for Military Personnel(GJB 826C-2022)is a new standard formulated after revision of the national military standard-Dietary Ration for Soldiers(GJB826B-2010).The major changes included that:①The daily standards of the ration for different types of stoveswere merged and integrated,and special requirements for food ration and food quality of personnel in special positions such as pilots,divers and those in direct contact with nuclear materials were specified;② The food structure was optimized.The daily standards of ration for grain,animal food,especially livestock and poultry meat were lowered while those for fruit and milk were increased.The requirements for the supply of whole grains were elevated while the proportions of lean meat,beef and mutton,seafood and other animal foods were detailed;③The new daily standards for nuts were added.The new standard could better meet the practical needsof actual combat,underscored dietary quality,and proved to be more user-friendly and practical.It is of great significance for improving the dietary nutrition of troops,creating a new dietary pattern to improve combat effectiveness,constructing a support system for joint military operations,and enhancing the military supply capabilities in China.
4. Analysis on maternal anemia rate and related factors in Taicang of Jiangsu Province in 2014-2016
Fang LI ; Cheng ZHANG ; Yugang CHEN ; Juying SHEN ; Shan JIANG ; Jun LI ; Shian YIN ; Zhenyu YANG ; Jianqiang LAI ; Jie WANG
Chinese Journal of Preventive Medicine 2018;52(7):703-708
Objective:
To investigate anemia rate and to analyze related factors in maternal women in Taicang of Jiangsu province.
Methods:
There were 13 278 pregnant women who had prenatal care and gave birth in 25 hospitals during 2014-2016 in Taicang of Jiangsu Province. We excluded 1 179 women who registered after 12 weeks of gestation, 144 women who did not test hemoglobin during gestation, and 25 women whose gestational weeks were incorrect. Finally, data from 11 930 pregnant women were analyzed. From the electronical medical record system of maternal and child health care, we obtained basic information of these pregnant women, their hemoglobin levels and related data during gestation and postpartum. Anemia rate was descripted, and factors associated with anemia were identified using multiple unconditional logistic regression.
Results:
Age of the 11 930 pregnant women was (27.0±4.5) years old, and the
5.The correlation of pulmonary ground-glass opacity imaging features and benign,malignant lesions
Haibing XU ; Xiaocui SHEN ; Yugang JI
Journal of Practical Radiology 2017;33(7):1006-1009
Objective To analyze the imaging features of ground-glass opacity (GGO) and provide advice for early diagnosis and treatment of malignant lung lesions.Methods The imaging findings of 56 GGOs scanned by MSCT on thin layer scanning were analyzed by χ2 test.Multivariate Logistic regression analysis was performed of the statistically significant variables for univariate analysis.Results Smoothness of the boundary, uniformity of the internal density, and spiculated margin of the GGO lesions were closely related to the diagnosis of malignant lesions.However,size,shape and distribution of the lesions were limited.Conclusion The distribution of GGO(internal, middle and outer band), border, internal density and spiculation are playing important role in early diagnosis of benign and malignant GGO.
6.Clinical Research on Treatment of Oligospermia and Asthenospermia with Guiqishengjing Capsule
Yugang WANG ; Zhuanxin JIANG ; Jianhong YU ; Xiaodong WANG ; Ming SHEN ; Yunling QIN
Journal of Kunming Medical University 2013;(10):96-99
Objective To observe the clinical efficacy of Guiqi shengjing capsule on infertility caused by oligospermia and asthenospermia. Methods All of 126 oligospermia and asthenospermia outpatients in theDepartment of Andrology from Sep 2011 to Dec 2012 were divided into 2 groups randomly:experimental group and control group (63 patients in each group), which were taken Guiqishengjing capsule and Huangjing zanyu capsule respectively, with a course of 3 months. Then we observed and compared the clinical efficacy and semen parameters of the patients in the 2 groups before and after treatment. Results There was no significant differences in semen parameters between two groups before treatment ( >0.05) .And also there was no significant differences in total clinical effective rate and semen parameters between two groups after treatment ( >0.05) .But, the extremely significant difference presented in sperm activity and density before and after treatment in two groups (<0.01) . Conclusion Guiqishengjing capsule can promote spermatogenesis, improve sperm quality, and has definite effect on oligospermia and asthenospermia in infertility .
7.Curative Effect of Implantation of AMS Three-piece Inflatable Penile Prosthesis on Severe Erectile Dysfunction
Yunling QIN ; Zhuanxin JIANG ; Xiaodong WANG ; Yugang WANG ; Jianhong YU ; Ming SHEN
Journal of Kunming Medical University 2013;(10):69-72
Objective To observe the clinical efficacy of AMS three- piece inflatable penile prosthesis on erectile dysfunction (ED).Methods From Dec 2008 to Sep 2012, 7 patiens with of serve erectile dysfunction (ED),whose ages were 28~55 years (average 47 years) were implanted with AMS three- piece inflatable penile prosthesis in our hospital. The 7 patients with serve erectile dysfunction included 3 patients with neurogenic ED,2 patients with arteriovenous fistula in corpus cavernosum penis and 2 patients with fibrosis of corpus cavernosum penis. Results All of the patients were performed smoothly with implantation of AMS three- piece inflatable penile prosthesis, among them 3 cases appeared foreskin edema, but it disappeared after 2 weeks. After 6~36 months (average 18 months) follow up, there was no rejection, no implant failure, and no urethral injury in our group, all patients got satisfaction on sexual life, and one patient with arteriovenous fistula in corpus cavernosum penis after treatment made his wife pregnant. Conclusion AMS three- piece inflatable penile prosthesis is close to human physiological penis, it has good concealment, less surgical trauma , high success rate, satisfying clinical efficacy, safe and reliable mechanical behavior.

Result Analysis
Print
Save
E-mail